Federica Barone

The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab.

A. Risitano, R. Notaro, P. Ricci, 2023, British Journal of Haematology.

Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life study

P. Scheinberg, A. Risitano, R. Calado, 2021, Bone Marrow Transplantation.

Hematological Response to Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: Application of a Novel Classification to Identify Unmet Clinical Needs and Future Clinical Goals

P. Scheinberg, A. Risitano, R. Calado, 2019, Blood.

COVID‐19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey

F. Lanza, R. Notaro, C. Carbone, 2021, British journal of haematology.